Accessibility Menu
Doximity Stock Quote

Doximity (NYSE: DOCS)

$67.71
(2.2%)
+1.46
Price as of October 24, 2025, 12:01 p.m. ET

KEY DATA POINTS

Current Price
$67.72
Daily Change
(2.2%) +$1.46
Day's Range
$67.01 - $68.08
Previous Close
$66.25
Open
$67.08
Beta
0
Volume
7,908
Average Volume
1,467,574
Market Cap
12.4B
Market Cap / Employee
$66.25M
52wk Range
$40.87 - $85.21
Revenue
-
Gross Margin
0.90%
Dividend Yield
N/A
EPS
$1.16
CAPs Rating
-
Industry
Health Care Technology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Doximity Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
DOCS+59.95%N/AN/A+25%
S&P+16.23%+94.45%+14.22%+58%

Doximity Company Info

Doximity, Inc. operates an online platform for medical professionals. Its cloud-based software has the ability to enable users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. The company was founded by Shari Buck, Konstantin Guericke, Nate Gross, and Jeffrey A. Tangney on April 16, 2010 and is headquartered in San Francisco, CA.

News & Analysis

The Fool has written over 100 articles on Doximity.

Financial Health

General

Q2 2025YOY Change
Revenue$145.91M15.2%
Gross Profit$130.12M15.0%
Gross Margin89.18%-0.1%
Market Cap$11.52B122.1%
Market Cap / Employee$13.88M0.0%
Employees8300.4%
Net Income$53.32M28.9%
EBITDA$57.48M17.7%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$137.26M23.2%
Accounts Receivable$144.86M17.3%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$9.67M-18.3%
Short Term Debt$2.17M-1.0%

Ratios

Q2 2025YOY Change
Return On Assets20.64%6.2%
Return On Invested Capital15.55%1.5%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$60.14M52.1%
Operating Free Cash Flow$62.10M50.6%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings50.1353.2952.4052.6649.72%
Price to Book8.8610.3710.5610.7084.86%
Price to Sales16.8919.6320.6520.9385.38%
Price to Tangible Book Value9.8711.4911.5911.6880.50%
Price to Free Cash Flow TTM40.1746.5344.1642.9425.00%
Enterprise Value to EBITDA136.23120.54210.47200.25102.14%
Free Cash Flow Yield2.5%2.1%2.3%2.3%-20.00%
Return on Equity19.0%21.2%22.5%24.3%43.82%
Total Debt$13.49M$12.95M$12.40M$11.84M-15.61%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.